PROCEPT BioRobotics Corp Reports Leadership Changes

Ticker: PRCT · Form: 8-K · Filed: Apr 19, 2024 · CIK: 1588978

Sentiment: neutral

Topics: leadership-change, officer-appointment, director-election, compensation

TL;DR

PROCEPT BioRobotics Corp filed an 8-K detailing director departures, new elections, officer appointments, and compensation changes.

AI Summary

PROCEPT BioRobotics Corporation filed an 8-K on April 18, 2024, reporting on the departure of a director, the election of new directors, the appointment of officers, and compensatory arrangements. The filing details changes in the company's leadership and executive compensation structure.

Why It Matters

Changes in corporate leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and stock performance.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure of leadership and compensation changes, not indicating immediate financial distress or significant operational shifts.

Key Players & Entities

FAQ

What specific items are being reported in this Form 8-K?

This Form 8-K reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.

What is the exact name of the registrant?

The exact name of the registrant is PROCEPT BIOROBOTICS CORPORATION.

In which state was PROCEPT BioRobotics Corporation incorporated?

PROCEPT BioRobotics Corporation was incorporated in Delaware.

What is the address of the principal executive offices?

The address of the principal executive offices is 150 Baytech Drive San Jose, California 95134.

What is the telephone number of the registrant?

The registrant's telephone number, including area code, is (650) 232-7200.

Filing Stats: 848 words · 3 min read · ~3 pages · Grade level 12.2 · Accepted 2024-04-19 17:29:44

Key Financial Figures

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File, formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROCEPT BIOROBOTICS CORPORATION Date: April 19, 2024 By: /s/ Alaleh Nouri Alaleh Nouri Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing